Many pitfalls in diagnosis of acute intermittent porphyria: A case report

被引:10
作者
Indika N.L.R. [1 ]
Kesavan T. [3 ]
Dilanthi H.W. [2 ]
Jayasena K.L.S.P.K.M. [2 ]
Chandrasiri N.D.P.D. [2 ]
Jayasinghe I.N. [2 ]
Piumika U.M.T. [2 ]
Vidanapathirana D.M. [2 ]
Gunarathne K.D.A.V. [2 ]
Dissanayake M. [3 ]
Jasinge E. [2 ]
Arachchi W.K. [3 ]
Doheny D. [4 ]
Desnick R.J. [4 ]
机构
[1] Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda
[2] Department of Chemical Pathology, Lady Ridgeway Hospital for Children, Colombo
[3] Teaching Hospital Karapitiya, Galle
[4] Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York
关键词
Acute intermittent porphyria; Acute porphyria; Genetic counseling; Hydroxymethylbilane synthase; Misdiagnosis; Mutation analysis; Porphobilinogen;
D O I
10.1186/s13104-018-3615-z
中图分类号
学科分类号
摘要
Background: Acute intermittent porphyria is a rare autosomal dominant disorder caused by a deficiency of the enzyme, hydroxymethylbilane synthase. Recognition of acute neurovisceral attacks can be difficult due to the nonspecific nature of symptoms. Case presentation: We report a case of 33-year-old male patient who presented with recurrent episodes of severe abdominal pain, nausea, vomiting, constipation and numbness of bilateral lower limb extremities. These nonspecific neurovisceral attacks were subject to medical and surgical misdiagnoses of acute appendicitis, sinus tachycardia, renal calculi, drug-induced acute interstitial nephritis and two episodes of partial intestinal obstruction. The sixth acute attack raised the suspicion of an acute porphyria. Watson and Schwartz test was positive for porphobilinogen in urine. Mutation analysis by DNA sequencing of the extracted DNA of the proband revealed a previously reported missense mutation, c.517C>T encoding p.R173W in the HMBS gene, confirming the diagnosis of Acute Intermittent Porphyria. Four out of five family members who underwent targeted mutation analyses were mutation-positive. Conclusion: The most common clinical presentation of Acute Intermittent Porphyria is abdominal pain with neurovisceral manifestations which are common to several medical, psychiatric and surgical pathologies. This leads to underdiagnosis and misdiagnosis of this disorder, incorrect management, and severe complications. Therefore, a high index of suspicion and awareness of front line laboratory investigations are important for diagnosis. Definitive diagnosis enables implementation of strategies to prevent acute attacks, and also triggers genetic testing and genetic counseling of at-risk family members. © 2018 The Author(s).
引用
收藏
相关论文
共 21 条
[1]  
Anderson K.E., Sassa S., Bishop D.F., Desnick R.J., Disorders of heme biosynthesis
[2]  
X-linked sideroblasticanaemia and the porphyrias, The Metabolic and Molecular Basis of Inherited Disease, pp. 2991-3062, (2001)
[3]  
Stenson P.D., Mort M., Ball E.V., Et al., The human gene mutation database: 2008 update, Genome Med, 1, 1, (2009)
[4]  
Puy H., Gouya L., Deybach J.C., Porphyrias, Lancet, 375, pp. 924-937, (2010)
[5]  
Whatley S.D., Badminton M.N., Acute Intermittent Porphyria, pp. 1993-2017, (2005)
[6]  
Elder G., Harper P., Badminton M., Sandberg S., Deybach J.C., The incidence of inherited porphyrias in Europe, J Inherit Metab Dis, 36, 5, pp. 849-857, (2013)
[7]  
Pierach C.A., Cardinal R., Bossenmaier I., Watson C.J., Comparison of the Hoesch and the Watson-Schwartz tests for urinary porphobilinogen, Clin Chem, 23, 9, pp. 1666-1668, (1977)
[8]  
Rossi E., Association of clinical pathologists [ACP] best practice no 165 front line tests for the investigation of suspected porphyria, Clin Biochem Rev, 24, 2, pp. 67-69, (2003)
[9]  
Whatley S.D., Badminton M.N., Role of genetic testing in the management of patients with inherited porphyria and their families, Ann Clin Biochem, 50, 3, pp. 204-216, (2013)
[10]  
Chen B., Solis-Villa C., Qiao W., Srinivasan R.R., Yasuda M., Et al., Acute intermittent porphyria: Predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease, Hum Mutat, 37, 11, (2016)